This is Fitbit's first major integration of a digital health platform and wearables into a national public health program globally.
The company's goal is to help get the most impactful health products to market faster and more responsibly.
Babyscripts monitors expectant mothers throughout pregnancy and sends pertinent health information to soon-to-be mothers and their physicians.
Launching in fall 2019, the new platform aims to revolutionize the healthcare industry for patients, medical professionals and politicians alike.
Called Transforming IBD Care, the challenge focuses on innovation in IBD monitoring, condition management or care enhancements.
The early-stage study took place over 12 weeks and included an 82-person healthy control group and 31 individuals with varying stages of cognitive decline.
The study, conducted by Olive AI, explored how hospital leaders aim to drive efficiency and reduce costs through investments in non-clinical technologies.
Preorders will begin on September 6th, with the aluminum version going for $280 for the 40mm size and $300 for the 44mm version.
Dubbed Data at the Point of Care (DPC), it aims to fill information gaps and offer a more complete picture of a patient's health and history.
Called Motion Medical, it aims to accelerate the development of medical technology and new minimally invasive treatments.